A novel role for astrocytic fragmented mitochondria in regulating morphine addiction

Jie Rao1, Weikang Sun1, Xinran Wang1

  • 1State Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, Hainan University, Haikou 570228, China.

PubMed

Insights

Morphine addiction involves neuroinflammation driven by astrocyte dysfunction. Targeting astrocyte metabolism with FK866 reduced inflammation and reversed addictive behaviors in mice.

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolism

Background:

  • Chronic morphine exposure leads to addictive behaviors and central nervous system neuroinflammation.
  • Astrocytes are implicated in brain diseases, but their role in morphine addiction-induced neuroinflammation is unclear.

Purpose of the Study:

  • To investigate the role of astrocytes in morphine addiction-induced neuroinflammation.
  • To explore the underlying mechanisms involving astrocyte metabolism and intercellular communication.

Main Methods:

  • Examined the interplay between neurons, astrocytes, and microglia in response to morphine.
  • Analyzed astrocyte glycolytic metabolism, mitochondrial function, and reactive oxygen species generation.
  • Utilized FK866 to inhibit the nicotinamide adenine dinucleotide salvage pathway and assess its effects.
  • Evaluated neuroinflammatory markers and addictive behaviors in a mouse model.

Main Results:

  • Morphine exposure increased astrocyte glycolysis, leading to mitochondrial dysfunction and release of inflammatory mediators.
  • Intercellular communication among neurons, astrocytes, and microglia was crucial for morphine-induced inflammation.
  • FK866 inhibited astrocytic glycolysis, restored mitochondrial homeostasis, and attenuated neuroinflammation.
  • FK866 treatment reversed morphine-induced addictive behaviors in mice.

Conclusions:

  • Astrocytic immunometabolism plays a critical role in morphine-induced neural and behavioral plasticity.
  • Targeting astrocytic metabolism offers a potential therapeutic strategy for morphine addiction.
  • This study reveals novel interactions between neurons, astrocytes, and microglia in the context of chronic morphine exposure.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
515
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
657
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
335
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.0K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
291
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K